Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Micrus reports on aneurysm trial for MicroCoil:

This article was originally published in Clinica

Executive Summary

Micrus has presented trial data on 120 intracranial aneurysms embolised using its minimally invasive ACT MicroCoil system. The product, which employs a heat resistive detachment system, was reported to be quick, effective and reliable in treating intracerebral aneurysms - principally wide neck lesions. The MicroCoil was used to treat patients with a wide variety of aneurysms and procedures done in both the anterior and posterior circulation of the brain were successful, said the Mountain View, California firm. The MicroCoil system gained US FDA and CE-mark approvals for sale last year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts